News

Welcome to the news and media section of our website, where we feature corporate news releases and media coverage of interest.

 

3 calves in a field

MCWF Greatly Improves Pregnancy Success in Heifer Embryo Transfer Recipients

An abstract being presented at the 2021 IETS Virtual Conference summarizes data from a study showing 45% of Amplimune-treated embryo transfer recipient heifers achieved pregnancy at Day 60 vs. 28% of untreated controls.

Holstein calf looking at camera

Amplimune® Receives Regulatory Approval in New Zealand

NovaVive's immunotherapy for calf scours - Amplimune® - has received approval for sale in New Zealand by Agricultural Compounds and Veterinary Medicines (ACVM). NovaVive has appointed Agilis Vet Ltd as its NZ distributor.

close-up of Bernese Mountain Dog

NovaVive Seeking to Enhance Quality of Life of Dogs with Cancer

Immunocidin is being evaluated in a clinical study as a palliative therapy for dogs with malignant cancer. The goal is to increase the dogs' comfort and maintain or improve the quality and duration of their remaining life.

before and after treatment photos

Results from a Study with Immunocidin® Equine for Sarcoid Tumors Being Published in the Journal of Equine Veterinary Science

An Iowa State University study concluded that Immunocidin Equine was effective in 52.9% of the cases enrolled (that had a known outcome) after 2-5 injections. The treatment was deemed safe, with swelling the only side effect.

mare and foal

Positive Effect of Settle® on Postpartum Involution Published in the Journal of Equine Veterinary Science

Data from a study with Settle® has been published in the Journal of Equine Veterinary Science. The data show a positive effect of Settle on postpartum uterine involution in the mare, particularly with a two-dose regimen.

mare and foal

Researchers Present Settle® Data to International Veterinary Scientists in Germany

Data from a University of Kentucky study assessing the effect of Settle on histological involution, cell-mediated immunity of the uterus, and clinical endpoints associated with involution was presented in Germany today.

Sign up to stay up-to-date with NovaVive news.